News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
103 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22867)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2493)
September (558)
Day
1 (26)
2 (174)
3 (177)
4 (143)
5 (222)
6 (34)
9 (203)
10 (137)
11 (95)
12 (124)
13 (105)
15 (21)
16 (103)
17 (104)
18 (170)
19 (133)
20 (75)
22 (7)
23 (133)
24 (158)
25 (111)
26 (117)
27 (109)
30 (214)
31 (134)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
2
3
4
5
6
9
10
11
12
13
15
16
17
18
19
20
22
23
24
25
26
27
30
31
Press Releases
Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign Prostatic Hyperplasia
March 16, 2026
·
5 min read
Press Releases
Amlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease
March 16, 2026
·
4 min read
Press Releases
Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
March 16, 2026
·
11 min read
Press Releases
Baxter Announces CFO Transition
March 16, 2026
·
3 min read
Press Releases
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
March 16, 2026
·
2 min read
Rare diseases
BioMarin Pauses Dosing, Enrollment in 2 Voxzogo Studies After Safety Signal
With Ascendis Pharma entering the achondroplasia space last month and BridgeBio on deck, BioMarin faces competition. Adding to the pressure, the company suffered a setback Monday when it halted two studies of Voxzogo in other growth-related conditions following multiple cases of hip injuries in other trials of the drug.
March 16, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Melius MicroBiomics Receives Australian DIR Licence as Key Step Toward Clinical Evaluation
March 16, 2026
·
3 min read
Press Releases
Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch
March 16, 2026
·
6 min read
Press Releases
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
March 16, 2026
·
9 min read
Press Releases
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
March 16, 2026
·
3 min read
Previous
8 of 11
Next
